Brainstorm Cell Therapeutics Inc. (BCLI)
Net Income Growth
8.09%
TTM · Period ending:
BCLI Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported8.09%period ending
Latest reported8.09%period ending
BCLI TTM Net Income YoY % (-56.59% → 8.09%)
Year-over-year change
High-resolution chart · PNG
BCLI net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 8.0887% | |
| 13.6749% | |
| 11.3224% | |
| 23.77% | |
| 10.1836% | |
| 28.634% | |
| 32.393% | |
| 14.4541% | |
| 42.7506% | |
| 35.2102% | |
| 29.184% | |
| 34.6458% | |
| 6.9503% | |
| -3.5457% | |
| 0.736% | |
| 15.4012% | |
| 18.1535% | |
| 23.7294% | |
| 23.1178% | |
| -8.6463% | |
| -1.3873% | |
| -15.2582% | |
| -36.8039% | |
| -32.2002% | |
| -55.9775% | |
| -57.9421% | |
| -66.7121% | |
| -152.6722% | |
| -145.9553% | |
| -205.1601% | |
| -181.664% | |
| -41.6439% | |
| -48.6845% | |
| -9.8051% | |
| 0.6022% | |
| -1.9157% | |
| 24.9889% | |
| 38.1124% | |
| 41.3054% | |
| 41.6107% | |
| 30.1803% | |
| 14.1821% | |
| 8.1981% | |
| -27.1693% | |
| -50.954% | |
| -58.0803% | |
| -88.7324% | |
| -81.4832% | |
| -47.7015% | |
| -62.8124% | |
| -42.7864% | |
| 0.3042% | |
| -13.384% | |
| 10.869% | |
| 12.4298% | |
| -43.3266% | |
| -27.607% | |
| -62.8139% | |
| -61.9678% | |
| -46.4637% | |
| -53.2002% | |
| -33.3156% | |
| -35.8226% | |
| 11.6319% | |
| 18.9963% | |
| 30.9104% | |
| 48.7039% | |
| 51.5152% | |
| 56.0518% | |
| 52.8883% | |
| 44.3961% | |
| 7.5907% | |
| -16.0238% | |
| -37.9528% | |
| -102.5961% | |
| -60.6085% | |
| -48.1351% | |
| -26.3674% | |
| 5.6101% | |
| 83.0992% | |
| 83.6156% | |
| 82.3225% | |
| 82.0933% | |
| -1,050.7894% | |
| -23,575.2704% | |
| -25,498.6234% | |
| -33,669.4692% | |
| -3,010.1339% | |
| -64.3419% | |
| -56.5932% |